Quick Answer
Zura Bio Ltd reported Diluted EPS of $1.06 per share (loss) for fiscal year 2025.
Zura Bio Ltd Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$1.06 | -76.7% |
| 2024 | -$0.60 | +71.3% |
| 2023 | -$2.09 | +98.5% |
| 2022 | -$141.97 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$0.21 | +19.2% | -23.5% |
| June 30, 2025 | -$0.17 | +0.0% | +10.5% |
| March 31, 2025 | -$0.19 | -850.0% | +26.9% |
| September 30, 2024 | -$0.26 | -44.4% | -52.9% |
| June 30, 2024 | -$0.17 | +87.0% | -750.0% |
| March 31, 2024 | -$0.02 | +99.3% | +88.9% |
| September 30, 2023 | -$0.18 | +93.7% | +86.3% |
| June 30, 2023 | -$1.31 | +86.3% | +52.5% |
- Zura Bio Ltd showed a decrease of -76.7% in Diluted EPS compared to the prior fiscal year.
- Over the 2022–2025 period, Zura Bio Ltd’s diluted eps has grown by 99.3% (from $141.97 per share (loss) to $1.06 per share (loss)).
- The most recent figure is from Zura Bio Ltd’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 19, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: